Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease.
The caudate nucleus from examples of Alzheimer's disease (mean age 68, range 51-77 yr) had a mean wet weight and total protein content that were significantly lower than control. Biochemical markers of various specific nerve cells were determined. These are thought to reflect intrinsic choliner...
Auteurs principaux: | Pearce, B, Palmer, A, Bowen, D, Wilcock, G, Esiri, M, Davison, A |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1984
|
Documents similaires
-
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
par: Bowen, D, et autres
Publié: (1983) -
The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry.
par: Wilcock, G, et autres
Publié: (1983) -
Reduced GLP-1R availability in the caudate nucleus with Alzheimer’s disease
par: Emma Barrett, et autres
Publié: (2024-06-01) -
TRPV4 mRNA is elevated in the caudate nucleus with NPH but not in Alzheimer’s disease
par: Hunter White, et autres
Publié: (2022-11-01) -
Interpretive monitoring in the caudate nucleus
par: Marianna Yanike, et autres
Publié: (2014-11-01)